share market

Boeing Stock Plummets 8% After Air India 787 Dreamliner Crash in Ahmedabad Crashes into Residential Area- What Netizens Are saying?

In a heartbreaking mid-air tragedy on June 12, 2025, an Air India Boeing 787 Dreamliner carrying 242 souls exploded into a residential sector of...

Boeing Stock Plunges 7% After Air India Plane Crash in Ahmedabad: Market Shockwaves...

The aviation industry experienced a seismic shock on June 12, 2025, when Boeing's stock price tumbled dramatically in pre-market trading, falling nearly 7% following...
spot_imgspot_img
FAQ
Reetam Bodhak

Belrise Industries IPO: GMP, Subscription Details, and Key Insights for Investors

The Indian IPO market continues to buzz with excitement as Belrise Industries steps into the spotlight, opening its much-anticipated public issue for subscription. For...
Reetam Bodhak
Cooll

Upcoming IPOs: Coal India Subsidiaries to File Draft Papers Soon—What Investors...

Coal India capital markets are abuzz with anticipation as two major subsidiaries of Coal India Limited prepare to take a significant step toward public...
Reetam Bodhak
Uniff

The Rise of Unified Data Tech Solutions: Inside 2025’s Most Anticipated...

In the bustling world of Indian IPOs, where dreams of wealth creation collide with harsh market realities, a new contender is stepping into the...
Reetam Bodhak
Intes

Integrity Infrabuild Developers IPO: Share Allotment Status, GMP & How to...

The financial markets are abuzz as Integrity Infrabuild Developers, one of India's fastest-growing infrastructure firms, completes its highly anticipated ₹550 crore IPO. Thousands of...
Reetam Bodhak
Belrr5 ff

Belrise Industries IPO: Should You Invest? Price Band, Details & Expert...

The Indian stock market is buzzing with the upcoming IPO of Belrise Industries, a diversified conglomerate aiming to raise Rs 2,150 crore. With the...
Reetam Bodhak
Accrfea ff

Accretion Pharmaceuticals IPO Off to Strong Start: 49% Subscription on Day...

The Indian pharmaceutical sector witnessed an exciting development as Accretion Pharmaceuticals initial public offering (IPO) opened to robust investor response, achieving 49% subscription within...